Literature DB >> 211169

Enhanced chemotactic and phagocytic activities of leukocytes in psoriasis vulgaris.

A Wahba, H A Cohen, M Bar-Eli, R Gallily.   

Abstract

Leukocytes derived from the peripheral blood of psoriatic patients demonstrated an enhanced chemotactic response compared with leukocytes from healthy subjects. No significant difference was detected between the chemotactic response of leukocytes from patients with minimal or no skin involvement and those from patients with extensive lesions. Psoriatic leukocytes also had a significantly higher capacity to engulf 125I labeled Shigella flexneri than control leukocytes. It is postulated that a decrease in the cyclic AMP/cyclic GMP ratio in psoriatic leukocytes, similar to the imbalance of these 2 cyclic nucleotides found in the lesional epidermis of psoriasis, might be the cause of their enhanced chemotactic and phagocytic activities.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 211169     DOI: 10.1111/1523-1747.ep12547117

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  25 in total

1.  Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method.

Authors:  B Guillot; M Coupe; M Alirezai; J P Bureau; J J Guilhou
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Myeloperoxidase of polymorphonuclear leukocytes in psoriasis vulgaris.

Authors:  H Greiten; M Rister; G K Steigleder
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  Leukopheresis for treatment of psoriasis: is therapeutical benefit related to reduced activities of neutral proteinases of polymorphonuclear leukocytes?

Authors:  W Gliński; D Barszcz; S Jabłońska; Z Zarebska; M Tigałonowa; E Janczura
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Chemotactic lipoxygenase products in sera from patients with psoriasis.

Authors:  K Fogh; T Ternowitz; K Kragballe; T Herlin
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

5.  Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare.

Authors:  D Barszcz; Z Zarebska; M Glińska-Ferenz; S Jabłońska; M Tigałonowa; W Gliński
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

6.  Decreased extracellular release of granule enzymes from in vitro-stimulated polymorphonuclear leukocytes in guttate psoriasis.

Authors:  W Glinski; M Tigalonowa; S Jablonska; E Janczura
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

7.  Activity of some lysosomal enzyme in rheumatoid and psoriatic arthritis.

Authors:  D Mikulíková; M Stancíková; K Trnavský; F Vlcek
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

Review 8.  The practical use of methotrexate in psoriasis.

Authors:  J P Tung; H I Maibach
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

9.  Defective natural-killer- and killer-cell activity associated with increased polymorphonuclear leukocyte adherence in psoriasis.

Authors:  S Majewski; M Wasik; S Jabłońska; M Kamiński; M Fraczykowska
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

10.  Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.

Authors:  A Lundin; L Håkansson; G Michaëlsson; P Venge
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.